Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Chart Review of Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels in Hyperlipidemia Patients With or Without Omega-3 Fatty Acid Ethyl Esters
jRCT1080224577Completed
- Sponsor
- Takeda
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of omega-3-acid ethyl ester in hyperlipidemia (2 arms), sponsored by Takeda. Primary endpoints: Change in serum eicosapentaenoic acid (EPA) level and Change in serum EPA/arachidonic acid (AA) ratio. Started Feb 2019; status: completed.
02
Drugs
omega-3-acid ethyl ester
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on jRCT1080224577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224577.